Gross margin and EBITDA margin improved year-over-year despite a 5.7% revenue decline, with cash flow and leverage metrics showing significant progress. Segment results were mixed, and inventory normalization is expected in 2Q25.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.